L’Oréal-UNESCO For Women in Science 2024 International Awards | CALL FOR NOMINATIONS
Posted: 8 May 2023 Closes: 28 June 2023 The 2024 edition of the Awards will designate five outstanding scientific researchers in the field of Life and Environmental Sciences, working in the following regions: Africa & the Arab States,…
Championing trailblazing women in healthtech
Posted: 8 May 2023 Three extraordinary women, who are driving change in the healthtech industry, are recipients of 2023 BioMelbourne Network Women in Leadership Awards. These innovators and enablers are tenacious risk-takers who are inspiring the next generation…
UBI launches PETRACKR Diabetes product for dogs and cats.
Posted: 4 May 2023 Universal Biosensors, is delighted to announce it has today launched its PETRACKR blood glucose monitoring product for dogs and cats with diabetes globally. To coincide with the launch, UBI announces it has signed three…
ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller
Posted: 4 May 2023 Telix today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalTrials.gov Identifier: NCT03849118). The results were featured in a late-breaking oral…
First Patients in Canada Imaged with Illuccix
Posted: 4 May 2023 Telix announces first patients have been imaged in Canada with its commercially available prostate cancer imaging agent, Illuccix® [kit for the preparation of gallium (68Ga) PSMA-11 for intravenous injection]. With Illuccix now available nationwide…
Immutep Receives Approval to Initiate INSIGHT-005 Trial Evaluating Eftilagimod Alpha and Anti-PD-L1 Therapy BAVENCIO
Posted: 4 May 2023 Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received regulatory approval from the Paul-Ehrlich-Institut (“PEI”), German Federal Institute for Vaccines and Biomedicines, to…
4DMedical conducts first commercial scan within VA
Posted: 4 May 2023 Respiratory imaging technology company 4DMedical Limited announces the successful completion of the first commercial XV LVAS scan within the VA, conducted at Harry S. Truman Memorial Veterans Hospital in Colombia, Missouri. First commercial scan…
Atmo Biosciences appoints world-renowned gastroenterologist Professor Eamonn Quigley as Medical Advisory Board Chair
Posted: 1 May 2023 Atmo Biosciences, a company commercializing the world’s first ingestible gas-sensing capsule that provides insights into gut health and microbiome function, today announced the appointment of renowned gastroenterologist Professor Eamonn Quigley as Chair of its…
Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China
Posted: 1 May 2023 Cartherics Pty Ltd, a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it has granted Shunxi Holding Group Co Ltd (“Shunxi”) a licence to develop, manufacture and commercialise…
Immutep Receives Approval to Initiate INSIGHT-005 Trial Evaluating Eftilagimod Alpha and Anti-PD-L1 Therapy BAVENCIO
Posted: 1 May 2023 Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received regulatory approval from the Paul-Ehrlich-Institut (“PEI”), German Federal Institute for Vaccines and Biomedicines, to…
Nominations are now open for the 2023 GSK Award for Research Excellence!
Posted: 27 April 2023 Closes: 16 June 2023 Nominations are now open for the 2023 GSK Award for Research Excellence! The GSK Award for Research Excellence (ARE) is one of the most prestigious and longstanding awards available to…
Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia
Posted: 27 April 2023 Cytiva and the University of Adelaide are collaborating with BioCina, an Australian-based multi-product biologics contract development and manufacturing organization (CDMO), to expand its facility in Adelaide to manufacture mRNA-based vaccines and therapies. Fellow Danaher…
